Godrej Agrovet Limited share price
NSE: GODREJAGRO · ISIN INE850D01014
Key numbers
- Market cap
- ₹ 12,657 Cr
- Current price
- ₹ 657.80
- 52-week high / low
- ₹ 727 / 506
- Stock P/E
- 29.2
- Book value
- ₹ 105.7
- Dividend yield
- 1.67%
- ROCE
- 20.3%
- ROE
- 21.4%
- Debt to equity
- 0.77
- Sales growth (3 yrs)
- 3.1%
- Profit growth (3 yrs)
- 16.1%
- 1-year return
- -8.0%
About Godrej Agrovet Limited
Godrej Agrovet Limited, an agri-business company, provides products and services that enhance crop and livestock yields in India and internationally. The company operates through Animal Feed, Vegetable Oil, Crop Protection, Dairy, Poultry and Processed Food, and Other segments. It offers animal feed, such as cattle, poultry, and aqua feed. The company also engages in the oil palm cultivation with approximately 75,000 hectares of plantations across Andhra Pradesh, Telangana, Tamil Nadu, Goa, Maharashtra, and Mizoram producing crude palm oil, crude palm kernel oil, and palm kernel cake. In addition, it produces and markets crop protection products, including plant growth regulators, bio-stimulants, herbicides, insecticides, fungicides, and fertilizers and organic manures. Further, the company manufactures and markets processed poultry and vegetarian products under the Real Good Chicken name; vegetarian and non-vegetarian ready-to-cook products under the Yummiez name; and processed food and milk and milk products under the Godrej Jersey brand. Additionally, it produces agrochemical active ingredients, bulk and formulations, and pharmaceutical intermediates. The company was…
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 2,125 | 2,603 | 2,713 | 2,323 | 2,852 |
| Operating profit | 147 | 270 | 242 | 139 | 240 |
| Net profit | 71 | 161 | 115 | 105 | 135 |
| EPS (₹) | 3.68 | 8.35 | 5.97 | 5.45 | 6.99 |
Concall summary (2026-08-12)
AI summary of the earnings call transcript · tone: Positive · source document
Guidance & outlook
- During Q1 FY27, we delivered consolidated sales of INR2,852 crores, representing year -on-year growth of 10% despite a challenging operating environment marked by a delayed monsoon and inflationary pressures arising from geopolitical tensions.
- Astec LifeSciences sustained its recovery momentum and continued at EBITDA breakeven compared with an EBITDA loss of INR11 crores in Q1 FY26.
Growth & demand
- The Animal Nutrition business delivered a strong quarter with revenue growth of 12.6%, driven by robust demand, improved realizations and 15% growth in cattle feed volume s.
- Branded volumes grew by approximately 6%, while Yummiez's volumes increased by 22%, in line with our strategy of building a higher -quality branded foods portfolio.
Margins & costs
- Profitability improved significantly with reported segment results growing at 29% and the underlying Godrej Agrovet Limited August 06, 2026 segment results increasing 36%, reflecting the benefits of strategic sourcing, operating leverage and continued cost discipline.
- Consequently, segment revenue declined by 16.2%, while the reduction in volumes also led to a contraction in segment margin.
Capex & expansion
- So one is, first and foremost, that we are in the middle of a very large expansion, area expansion drive.
- So Probal, in any case, we have given a guidance of roughly around INR300-odd crores to INR350 crores of overall capex at a business level.
Balance sheet & cash
- Our Bangladesh joint venture, ACI, Godrej Agrovet, also returned to a strong growth trajectory, delivering double-digit growth in volumes, revenue and PBT, supported by broad-based volume expansion and operating leverage.
- Our average net working capital improved significantly year -on-year.
Peers in Packaged Foods
Data for information only, not investment advice. Prices end of day.